AI-Driven Discovery of Targeted Antibiotics for Gut Bacteria and IBD
The article discusses the discovery of a narrow-spectrum antibiotic guided by artificial intelligence and mechanistic studies, highlighting advances in antibiotic development and bacterial resistance understanding.